Cyclopentanone derivatives
    4.
    发明授权
    Cyclopentanone derivatives 失效
    环戊烷酮衍生物

    公开(公告)号:US3801623A

    公开(公告)日:1974-04-02

    申请号:US3801623D

    申请日:1971-04-28

    Applicant: ROUSSEL UCLAF

    CPC classification number: C07C405/00 C07C59/90 C07D309/12

    Abstract: NOVEL PROSTANOIC ACID DERIVATIVES OF THE FORMULA

    2-R1,2-(R-OOC-(CH2)N-CH=CH-CH2-),3-(CH3-(CH2)M-CH(-O-R3)-

    CH=CH-),5-R2-CYCLOPENTANONE

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

Patent Agency Ranking